Schwartz N B, Domowicz M, Krueger R C, Li H, Mangoura D
Department of Pediatrics, University of Chicago, Illinois 60615, USA.
Perspect Dev Neurobiol. 1996;3(4):291-306.
During development, the extracellular matrix (ECM) is a complex dynamic structure whose components and organization help to establish the requisite position and state of differentiation. Until recently, the large chondroitin sulfate proteoglycan, aggrecan, has been localized predominantly to skeletal tissue and considered a hallmark of cartilage differentiation. We have identified the presence of aggrecan in two other highly differentiated systems, brain and notochord, with clearly distinct expression patterns. In chick cartilage, aggrecan starts to be expressed at embryonic day 5 in limb rudiments, continues through the entire period of chondrocyte development, and remains a biochemical marker of the cartilage phenotype thereafter. In brain, aggrecan has a very low level of expression beginning at day 7, increases up to day 13, markedly decreases after day 16, and is not expressed posthatching. This pattern coincides with migration and establishment of neuronal nuclei in the chick telencephalon and has been proposed to be a component of the migration arrest mechanism. In very primitive embryos, aggrecan is detected as early as stage 16 in the notochord, long before chondrogenesis occurs, is then expressed up to day 5 and decreases thereafter. The expression of aggrecan occurs during the time of active neural crest migration and through the onset of sclerotomal differentiation, and correlates with the notochords' ability to inhibit neural crest cell migration. Animal models defective in aggrecan biosynthesis have been invaluable in delineating these functions. In addition we have characterized these proteoglycans by chemical, biosynthetic, and molecular analyses. Although significant post-translation differences distinguish the cell-specific aggrecan species, their core proteins are the products of a single gene. Our findings of the expression of the same gene (aggrecan) in multiple ontogenously unrelated differentiating tissue systems and at different times over the developmental life of an organism provide an elegant model system to study the regulation and interplay in expression of that gene, as well as the effect of alterations in that single gene simultaneously in several developing programs.
在发育过程中,细胞外基质(ECM)是一种复杂的动态结构,其成分和组织有助于确立分化所需的位置和状态。直到最近,大型硫酸软骨素蛋白聚糖(聚集蛋白聚糖)主要定位于骨骼组织,并被视为软骨分化的标志。我们已经在另外两个高度分化的系统——脑和脊索中发现了聚集蛋白聚糖的存在,其表达模式明显不同。在鸡软骨中,聚集蛋白聚糖在胚胎第5天开始在肢体原基中表达,在软骨细胞发育的整个阶段持续表达,此后一直是软骨表型的生化标志物。在脑中,聚集蛋白聚糖从第7天开始表达水平很低,到第13天增加,在第16天后显著下降,孵化后不再表达。这种模式与鸡端脑中神经元核的迁移和确立相吻合,并被认为是迁移停滞机制的一个组成部分。在非常原始的胚胎中,早在第16阶段就在脊索中检测到聚集蛋白聚糖,远在软骨形成发生之前,然后表达至第5天,此后下降。聚集蛋白聚糖的表达发生在神经嵴活跃迁移期间以及通过生骨节分化开始时,并与脊索抑制神经嵴细胞迁移的能力相关。聚集蛋白聚糖生物合成有缺陷的动物模型在阐明这些功能方面具有重要价值。此外,我们通过化学、生物合成和分子分析对这些蛋白聚糖进行了表征。尽管翻译后存在显著差异区分细胞特异性的聚集蛋白聚糖种类,但其核心蛋白是单个基因的产物。我们发现在多个个体发育上不相关的分化组织系统中以及在生物体发育生命的不同时间表达同一基因(聚集蛋白聚糖),这为研究该基因表达的调控和相互作用以及该单个基因同时在几个发育程序中的改变所产生的影响提供了一个绝佳的模型系统。